Get All Access for $5/mo

Tata Capital Healthcare Fund Pumps USD 20 Mn into Orbicular Pharmaceutical to Fuel R&D A Hyderabad-based specialty pharmaceutical company will deploy the raised capital to accelerate the development of the product pipeline.

By Entrepreneur Staff

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

[L-R] Dr M S Mohan (MD) & Dr Hiren Patel (CEO), Orbicular

Healthcare-focused private equity fund Tata Capital Healthcare Fund II (TCHF II) announced that it has invested an amount of USD 20 million in Orbicular Pharmaceutical Technologies Private Limited for an undisclosed equity stake.

As per the official release, Orbicular will deploy the raised capital to accelerate the development of the product pipeline.

Dr M S Mohan, Managing Director, Orbicular, said, "Today is a transformative milestone in our journey from starting as a bootstrapped company to successfully being backed by Tata Capital Healthcare Fund. Having positioned Orbicular as a differentiated specialty pharmaceutical company in the complex generics space, the investment will further strengthen our global partnerships."

This collaboration has been greatly aided by the contributions of Ritesh Desai, Executive Director of Pharma and Healthcare Investment Banking, and Vikas Khattar, MD, Co-Head of Investment Banking and ECM at Ambit.

Ambit acted as the exclusive financial advisor to Orbicular and its shareholders on this transaction.

Founded in 2010, Orbicular is a specialised pharmaceutical firm that specialises in complicated generics. Its pipeline includes complex injectables, topicals, ophthalmics, parenterals, nasal sprays or inhalations, and complex peptide combination products that target various treatment indications.

Dr Hiren Patel, Chief Executive Officer, Orbicular, said, "This new partnership with Tata Capital Healthcare Fund is a testament to our capabilities and will enable us to accelerate our R&D efforts, expand our portfolio, and strengthen our global partnerships."

Tata Capital Limited-sponsored TCHF is a growth-oriented private equity fund that makes investments in the healthcare and life sciences industries. Having invested in 18 companies and exited six of them, it has raised almost USD 200 million in two funds.

"We are proud to support the dynamic team at Orbicular and be a part of their growth story. This investment reinforces our fund's core philosophy of identifying the big shifts in the industry and being a "capital plus" partner to our companies," added Visalakshi Chandramouli, Managing Partner, Tata Capital Healthcare Fund.

Entrepreneur Staff

Entrepreneur Staff


For more than 30 years, Entrepreneur has set the course for success for millions of entrepreneurs and small business owners. We'll teach you the secrets of the winners and give you exactly what you need to lay the groundwork for success.
Side Hustle

Top Secrets to Starting a 6-Figure Etsy Side Hustle That Earns Passive Income, According to 3 People Who Did It

Etsy remains a popular ecommerce platfrom for sellers — and can be incredibly lucrative for those who know how to use it.

Starting a Business

3 Essential Skills I Learned By Growing My Business From the Ground Up

Discover the most effective (and cheapest) way for founders to learn team management, efficient decision-making and other essential leadership skills.

Business News

Amazon Is Thinking About Charging Extra for AI Alexa

"Hey Alexa, how much are you going to cost?"

News and Trends

Nirwana.AI Raises INR 100 Crores Seed Funding to Revolutionize Interior Design

With its first-mover advantage in India, Nirwana.AI provides designers and homeowners with quick ideation tools, powerful product visualization, and extensive user control

Business News

Amazon Is Making a Major Change to Its Packaging: 'Easier to Work With'

Opening an Amazon box is about to look a lot different.

Business News

SoftBank CEO Says AI 10x Smarter Than Humans Could Be Here in a Matter of Years

SoftBank CEO Masayoshi Son spoke to shareholders during the company's general meeting on Friday.